Rhot1-flox Mouse
Common Name
Rhot1-flox
제품 ID
S-CKO-12496
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-59040-Rhot1-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Rhot1-flox Mouse (카탈로그 번호 S-CKO-12496)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Rhot1-flox
품종 계통계통 ID
CKOCMP-59040-Rhot1-B6J-VA
유전자명
제품 ID
S-CKO-12496
유전자 별칭
Arht1, Miro1, 2210403N23Rik, C430039G08Rik
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 11
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000055056
NCBI 전사체 ID
NM_001163355
타겟 영역
Exon 2
유효 영역 크기
~0.9 kb
유전자 연구 개요
Rhot1, also known as Miro1, is a mitochondrial transport protein and a calcium-binding membrane-anchored GTPase. It is involved in multiple biological processes, such as mitochondrial dynamics, intracellular calcium homeostasis, and mitochondrial quality control. Rhot1 is associated with pathways like mitophagy and the regulation of mitochondria-ER contact sites, playing a significant role in maintaining cell function and viability [3,5,6,9].
In cancer research, genetic models have been revealing its role. In hepatocellular carcinoma (HCC), Rhot1 promotes mitochondrial transfer between HCC cells, enhancing the migration and invasion ability of less invasive cells. Under hypoxia, HMGB1 upregulates Rhot1 expression, further promoting these processes [1]. In breast cancer, exosomal circRNA Rhot1 promotes cancer progression by targeting the miR-204-5p/PRMT5 axis [8].
In bone-related studies, conditional knockout (CKO) of Rhot1 in osteocytes impairs mitochondrial transfer to metastatic cancer cells, reducing tumor immunogenicity and leading to cancer progression towards the bone matrix [2]. Also, CKO of Rhot1 in osteocytes causes regression of the transcortical vessel (TCV) network, as osteocytes rely on Rhot1-mediated mitochondrial transfer to maintain the normal TCV network [4].
In the context of Parkinson's disease, while some genetic analyses did not find evidence that common and low-frequency variants in Rhot1 are disease-causing or modifying genes for PD risk or age at onset, mutations in Rhot1 have been linked to impaired calcium homeostasis, structural alterations of mitochondria-ER contact sites, and increased mitochondrial clearance in patient-based cellular models [3,7].
In lung inflammation, epithelial ablation of Rhot1 in mice augmented the inflammatory cell infiltration and alteration in inflammatory mediators induced by cigarette smoke, indicating its role in regulating lung inflammatory responses related to mitochondrial quality control [9].
In conclusion, Rhot1 is crucial for various biological functions including mitochondrial transfer, cell migration, and invasion in cancer, tumor immunogenicity in bone metastasis, angiogenesis of TCVs, and regulation of lung inflammation. The use of Rhot1 KO/CKO mouse models and other genetic models has significantly contributed to understanding its role in these disease areas, providing insights into potential therapeutic strategies for cancer, Parkinson's disease, and lung-related inflammatory diseases.
References:
1. Jing, Mengjia, Xiong, Xiaofeng, Mao, Xin, Fu, Yu, Yan, Wei. 2024. HMGB1 promotes mitochondrial transfer between hepatocellular carcinoma cells through RHOT1 and RAC1 under hypoxia. In Cell death & disease, 15, 155. doi:10.1038/s41419-024-06536-6. https://pubmed.ncbi.nlm.nih.gov/38378644/
2. Zhou, Hao, Zhang, Wenkan, Li, Hengyuan, Gao, Junjie, Ye, Zhaoming. 2024. Osteocyte mitochondria inhibit tumor development via STING-dependent antitumor immunity. In Science advances, 10, eadi4298. doi:10.1126/sciadv.adi4298. https://pubmed.ncbi.nlm.nih.gov/38232158/
3. Grossmann, Dajana, Berenguer-Escuder, Clara, Chemla, Axel, Arena, Giuseppe, Krüger, Rejko. 2020. The Emerging Role of RHOT1/Miro1 in the Pathogenesis of Parkinson's Disease. In Frontiers in neurology, 11, 587. doi:10.3389/fneur.2020.00587. https://pubmed.ncbi.nlm.nih.gov/33041957/
4. Liao, Peng, Chen, Long, Zhou, Hao, Zheng, Minghao, Gao, Junjie. 2024. Osteocyte mitochondria regulate angiogenesis of transcortical vessels. In Nature communications, 15, 2529. doi:10.1038/s41467-024-46095-0. https://pubmed.ncbi.nlm.nih.gov/38514612/
5. König, Tim, Nolte, Hendrik, Aaltonen, Mari J, Langer, Thomas, McBride, Heidi M. 2021. MIROs and DRP1 drive mitochondrial-derived vesicle biogenesis and promote quality control. In Nature cell biology, 23, 1271-1286. doi:10.1038/s41556-021-00798-4. https://pubmed.ncbi.nlm.nih.gov/34873283/
6. Yao, Ren-Qi, Ren, Chao, Xia, Zhao-Fan, Yao, Yong-Ming. 2020. Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles. In Autophagy, 17, 385-401. doi:10.1080/15548627.2020.1725377. https://pubmed.ncbi.nlm.nih.gov/32048886/
7. Periñán, María Teresa, Gómez-Garre, Pilar, Blauwendraat, Cornelis, Mir, Pablo, Bandres-Ciga, Sara. 2020. The role of RHOT1 and RHOT2 genetic variation on Parkinson disease risk and onset. In Neurobiology of aging, 97, 144.e1-144.e3. doi:10.1016/j.neurobiolaging.2020.07.003. https://pubmed.ncbi.nlm.nih.gov/32948353/
8. Jiang, Weihua, Yu, YinPing, Ou, Jianghua, Li, Yongtao, Zhu, Ning. 2023. Exosomal circRNA RHOT1 promotes breast cancer progression by targeting miR-204-5p/ PRMT5 axis. In Cancer cell international, 23, 260. doi:10.1186/s12935-023-03111-5. https://pubmed.ncbi.nlm.nih.gov/37924099/
9. Sharma, Shikha, Wang, Qixin, Muthumalage, Thivanka, Rahman, Irfan. 2021. Epithelial Ablation of Miro1/Rhot1 GTPase Augments Lung Inflammation by Cigarette Smoke. In Pathophysiology : the official journal of the International Society for Pathophysiology, 28, 501-512. doi:10.3390/pathophysiology28040033. https://pubmed.ncbi.nlm.nih.gov/35366248/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
